Significant investments have been made in the field of poverty-related and emerging infectious diseases over the last years, thanks to global efforts, including by the EU. However, the burden remains high, with the COVID-19 pandemic highlighting the global and devastating impact that infectious diseases can have. The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.
The event will provide potential applicants with specific information on the new Global Health EDCTP3 Work Programme calls, funding opportunities and timelines. The Commission invites researchers and innovators as well as citizens and all interested stakeholders to take part in the Info Day.
Launched in 2003, the European and Developing Countries Clinical Trials Partnership (EDCTP) exists to accelerate the clinical development of new or improved medicinal products for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including (re-)emerging diseases. In addition, the EDCTP funds activities for research capacity building in Africa, supporting researchers’ careers and strengthening national health research systems.
- Publication date
- 10 May 2022
- Directorate-General for Research and Innovation